awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38722972-9717C6B2-8009-4D66-90B2-61BF3B2893C5
Q38722972-9717C6B2-8009-4D66-90B2-61BF3B2893C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-9717C6B2-8009-4D66-90B2-61BF3B2893C5
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.
P2860
Q38722972-9717C6B2-8009-4D66-90B2-61BF3B2893C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-9717C6B2-8009-4D66-90B2-61BF3B2893C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47ebfb264f33242af89da942a117752428f112a1
P2860
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.